Crohn Disease Clinical Trials in Charlotte, North Carolina

4 studies are recruiting for crohn disease in Charlotte, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Atrium Health, Charlotte, North Carolina
    Locations
    370 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07196722 on ClinicalTrials.gov

  2. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Charlotte Gastroenterology and Hepatology, PLLC, Charlotte, North Carolina
    Locations
    160 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07499232 on ClinicalTrials.gov

  3. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pain, diarrhea, blood in the stool, weight loss, or delayed growth in children. While the exact cause …

    Stage
    Phase 4
    Ages
    6 to 17
    Site
    Levine Children's, Charlotte, North Carolina
    Locations
    26 in total
    Run by
    Connecticut Children's Medical Center

    See if you can join NCT05781152 on ClinicalTrials.gov

  4. COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

    The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD). Refractory means that there was no clinical response to anti-tumor necrosis factor (T…

    Stage
    Not phased
    Ages
    1 to 18
    Site
    Atrium Health, Charlotte, North Carolina
    Locations
    4 in total
    Run by
    University of North Carolina, Chapel Hill

    See if you can join NCT07198113 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.